BMPR1B
MOLECULAR TARGETbone morphogenetic protein receptor type 1B
BMPR1B (bone morphogenetic protein receptor type 1B) is targeted by 26 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting BMPR1B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | sb 203580 | 4.92 | 136 |
| 2 | alvocidib | 4.52 | 91 |
| 3 | tozasertib | 4.33 | 75 |
| 4 | vandetanib | 4.30 | 73 |
| 5 | ruxolitinib | 4.23 | 68 |
| 6 | quizartinib | 3.99 | 53 |
| 7 | pazopanib | 3.69 | 39 |
| 8 | canertinib | 3.53 | 33 |
| 9 | tae 684 | 3.43 | 30 |
| 10 | fedratinib | 3.40 | 29 |
| 11 | gilteritinib | 3.40 | 29 |
| 12 | linifanib | 3.33 | 27 |
| 13 | mln 8054 | 3.33 | 27 |
| 14 | saracatinib | 3.33 | 27 |
| 15 | dorsomorphin | 3.14 | 22 |
| 16 | at 9283 | 3.09 | 21 |
| 17 | lestaurtinib | 3.04 | 20 |
| 18 | momelotinib | 2.89 | 17 |
| 19 | r 406 | 2.83 | 16 |
| 20 | plx 4720 | 2.71 | 14 |
| 21 | kw 2449 | 2.64 | 13 |
| 22 | tak 285 | 2.40 | 10 |
| 23 | su 014813 | 2.20 | 8 |
| 24 | asp 3026 | 2.08 | 7 |
| 25 | Axitinib | 0.69 | 1 |
| 26 | Crizotinib | 0.69 | 1 |
About BMPR1B as a Drug Target
BMPR1B (bone morphogenetic protein receptor type 1B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 26 compounds with documented BMPR1B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
BMPR1B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.